DE69227942T2 - Metaboliten von Rapamycin - Google Patents

Metaboliten von Rapamycin

Info

Publication number
DE69227942T2
DE69227942T2 DE69227942T DE69227942T DE69227942T2 DE 69227942 T2 DE69227942 T2 DE 69227942T2 DE 69227942 T DE69227942 T DE 69227942T DE 69227942 T DE69227942 T DE 69227942T DE 69227942 T2 DE69227942 T2 DE 69227942T2
Authority
DE
Germany
Prior art keywords
mass
charge ratio
rapamycin
virtue
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69227942T
Other languages
English (en)
Other versions
DE69227942D1 (de
Inventor
Uwe Christians
Karl Friedrich Sewing
Martin Sattler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of DE69227942D1 publication Critical patent/DE69227942D1/de
Application granted granted Critical
Publication of DE69227942T2 publication Critical patent/DE69227942T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69227942T 1991-05-14 1992-05-13 Metaboliten von Rapamycin Expired - Fee Related DE69227942T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/699,505 US5776943A (en) 1991-05-14 1991-05-14 Rapamycin metabolites

Publications (2)

Publication Number Publication Date
DE69227942D1 DE69227942D1 (de) 1999-02-04
DE69227942T2 true DE69227942T2 (de) 1999-08-26

Family

ID=24809620

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69227942T Expired - Fee Related DE69227942T2 (de) 1991-05-14 1992-05-13 Metaboliten von Rapamycin

Country Status (13)

Country Link
US (1) US5776943A (de)
EP (1) EP0514144B1 (de)
JP (1) JP3183554B2 (de)
KR (1) KR920021552A (de)
AT (1) ATE174918T1 (de)
AU (1) AU659452B2 (de)
CA (1) CA2068349C (de)
DE (1) DE69227942T2 (de)
DK (1) DK0514144T3 (de)
ES (1) ES2126586T3 (de)
GR (1) GR3029767T3 (de)
HK (1) HK1010369A1 (de)
IE (1) IE921525A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9302569D0 (en) * 1993-02-10 1993-03-24 Smithkline Beecham Plc Novel compound
GB9315914D0 (en) * 1993-07-31 1993-09-15 Smithkline Beecham Plc Novel compound
WO1996006847A1 (en) * 1994-08-31 1996-03-07 Pfizer Inc. Process for preparing demethylrapamycins
US5922730A (en) * 1996-09-09 1999-07-13 American Home Products Corporation Alkylated rapamycin derivatives
IT1289815B1 (it) * 1996-12-30 1998-10-16 Sorin Biomedica Cardio Spa Stent per angioplastica e relativo procedimento di produzione
US6015809A (en) * 1998-08-17 2000-01-18 American Home Products Corporation Photocyclized rapamycin
ATE420160T1 (de) * 2003-06-18 2009-01-15 Genelux Corp Modifizierte rekombinante vacciniaviren, verwendungen davon
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
US8414526B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
US8414909B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US9737640B2 (en) 2006-11-20 2017-08-22 Lutonix, Inc. Drug releasing coatings for medical devices
US20080276935A1 (en) 2006-11-20 2008-11-13 Lixiao Wang Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
US9700704B2 (en) 2006-11-20 2017-07-11 Lutonix, Inc. Drug releasing coatings for balloon catheters
US8414910B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8425459B2 (en) 2006-11-20 2013-04-23 Lutonix, Inc. Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
US8430055B2 (en) 2008-08-29 2013-04-30 Lutonix, Inc. Methods and apparatuses for coating balloon catheters
US8998846B2 (en) 2006-11-20 2015-04-07 Lutonix, Inc. Drug releasing coatings for balloon catheters
US8414525B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA737247B (en) * 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
US3993749A (en) * 1974-04-12 1976-11-23 Ayerst Mckenna And Harrison Ltd. Rapamycin and process of preparation
US4885171A (en) * 1978-11-03 1989-12-05 American Home Products Corporation Use of rapamycin in treatment of certain tumors
US4316885A (en) * 1980-08-25 1982-02-23 Ayerst, Mckenna And Harrison, Inc. Acyl derivatives of rapamycin
US4401653A (en) * 1981-03-09 1983-08-30 Ayerst, Mckenna & Harrison Inc. Combination of rapamycin and picibanil for the treatment of tumors
US4650803A (en) * 1985-12-06 1987-03-17 University Of Kansas Prodrugs of rapamycin
US4981792A (en) * 1988-06-29 1991-01-01 Merck & Co., Inc. Immunosuppressant compound
US5100899A (en) * 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
EP0413532A3 (en) * 1989-08-18 1991-05-15 Fisons Plc Macrocyclic compounds
US5023264A (en) * 1990-07-16 1991-06-11 American Home Products Corporation Rapamycin oximes
US5023263A (en) * 1990-08-09 1991-06-11 American Home Products Corporation 42-oxorapamycin
US5023262A (en) * 1990-08-14 1991-06-11 American Home Products Corporation Hydrogenated rapamycin derivatives
FI921595A (fi) * 1991-04-17 1992-10-18 American Home Prod Rapamycinkarbamater
US5091389A (en) * 1991-04-23 1992-02-25 Merck & Co., Inc. Lipophilic macrolide useful as an immunosuppressant
FI97472C (fi) * 1991-05-07 1996-12-27 American Home Prod Menetelmä terapeuttisesti käyttökelpoisten rapamysiinijohdannaisten valmistamiseksi anti-inflammatorisina ja antifungaalisina aineina
US5102876A (en) * 1991-05-07 1992-04-07 American Home Products Corporation Reduction products of rapamycin

Also Published As

Publication number Publication date
ATE174918T1 (de) 1999-01-15
DE69227942D1 (de) 1999-02-04
KR920021552A (ko) 1992-12-18
CA2068349A1 (en) 1992-11-15
EP0514144A2 (de) 1992-11-19
HK1010369A1 (en) 1999-06-17
EP0514144A3 (en) 1993-03-03
ES2126586T3 (es) 1999-04-01
EP0514144B1 (de) 1998-12-23
IE921525A1 (en) 1992-11-18
AU1615492A (en) 1992-11-19
US5776943A (en) 1998-07-07
JP3183554B2 (ja) 2001-07-09
CA2068349C (en) 2002-04-09
JPH05130884A (ja) 1993-05-28
GR3029767T3 (en) 1999-06-30
DK0514144T3 (da) 1999-08-23
AU659452B2 (en) 1995-05-18

Similar Documents

Publication Publication Date Title
DE69227942T2 (de) Metaboliten von Rapamycin
DE59107529D1 (de) Massenspektrometrischer Hochfrequenz-Quadrupol-Käfig mit überlagerten Multipolfeldern
WO1997015054A3 (en) A flash eeprom memory with separate reference array
WO1998056023A3 (en) Miniature micromachined quadrupole mass spectrometer array and method of making the same
DE59007546D1 (de) MS-MS-Flugzeit-Massenspektrometer.
AU4149797A (en) Multipole ion guide ion trap mass spectrometry
EP0237259A3 (de) Massenspektrometer
AU7515996A (en) Miniature quadrupole mass spectrometer array
CA2355552A1 (en) Mass spectrometers and methods of mass spectrometry
NO173390C (no) Analogifremgangsm}te for fremstilling av terapeutisk virksomme 1,2-bis(aminometyl)-cyklobutan-platinakomplekser
DE68921370T2 (de) Electronzyklotronresonanz-Ionenquelle.
DE69118121T2 (de) Quadrupolmassenspektrometers
CA2101156A1 (en) Chemical Ionization Mass Spectrometry Method Using Notch Filter
DE69402513T2 (de) Quadrupolmassenspektrometer
NO913790D0 (no) Separator for smaa partikler.
DE69202782T2 (de) Feldemissions-Elektronenkanone geringer Aberration.
DE58909253D1 (de) Icr-ionenfalle.
Bakthavachalam et al. Selection of electrophoric derivatives of 1-aminopyrene and 2-aminofluorene for determination by gas chromatography with electron-capture negative-ion mass spectrometry
Roboz et al. Collisional activation decomposition of actinomycins using tandem mass spectrometry
ATE480865T1 (de) Massenspektrometer und massenspektrometrische verfahren
Ramanathan Internal and external source electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
Neale The future of BiCMOS-is there one?
Dreier et al. MASS SPECTRA OF 1-SUBSTITUTED-3-FORMYL-2 (1 H)-PYRIDONES,-THIONES AND-SELONES
Rasulev et al. The peculiarities of sputtering of metals and semiconductors by molecular ions
Cao Comparative study of the performance of hydrogen vs helium in the operation of GC/quadrupole ion trap mass spectrometer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: WYETH (N.D.GES.D. STAATES DELAWARE), MADISON, N.J.

8339 Ceased/non-payment of the annual fee